Search Editorial Photos
"evolving challenges"
19 professional editorial images found
#13295613
9 Feb 2026
The CSL logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295615
9 Feb 2026
The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295626
9 Feb 2026
The Novartis logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295612
9 Feb 2026
The Bristol Myers Squibb logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295614
9 Feb 2026
The Dynavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295617
9 Feb 2026
The Novavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295619
9 Feb 2026
The GSK logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295620
9 Feb 2026
The Roche logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295628
9 Feb 2026
The Pfizer logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295632
9 Feb 2026
The Valneva logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#13295607
9 Feb 2026
The AbbVie logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12173757
19 Mar 2025
A busy urban street in Thanh Hoa, Vietnam, on March 19, 2025, is filled with parked motorbikes and moving cars as pedestrians shop and navigate the sidewalks. The area is lined with illuminated storefronts, fashion boutiques, and restaurants, creating a vibrant commercial district where people engage in daily activities amidst the evening rush.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12173759
19 Mar 2025
A busy urban street in Thanh Hoa, Vietnam, on March 19, 2025, is filled with parked motorbikes and moving cars as pedestrians shop and navigate the sidewalks. The area is lined with illuminated storefronts, fashion boutiques, and restaurants, creating a vibrant commercial district where people engage in daily activities amidst the evening rush.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11949292
15 Jan 2025
LAS VEGAS, USA - JANUARY 09: The ANSYS booth displays the Red Bull Racing RB18, a Formula One car which competed in the 2022 Formula One World Championship, at CES 2025, in Las Vegas, Nevada, USA, on January 9, 2025. Ansys software enables students, engineers, and manufacturers to address the challenges of developing software-defined vehicles by designing and validating new features virtually without the need for costly hardware testing, enhancing driver safety through risk assessment in simulated environments, and accelerating design cycles by leveraging artificial intelligence and simulation to meet evolving demands and introduce innovative products.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11949293
15 Jan 2025
LAS VEGAS, USA - JANUARY 09: The ANSYS booth features the Ferrari 296 GT3, winner of the GTD Pro class at the 2024 24 Hours of Daytona, showcased during CES 2025 in Las Vegas, Nevada, USA, on January 9, 2025. Ansys software empowers students, engineers, and manufacturers to overcome the challenges of developing software-defined vehicles by enabling virtual design and feature validation without costly hardware testing, enhancing driver safety through comprehensive risk assessment in simulated environments, and accelerating design cycles with the integration of artificial intelligence and advanced simulation tools to meet evolving industry demands and drive innovative breakthroughs.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11949295
15 Jan 2025
LAS VEGAS, USA - JANUARY 09: The ANSYS logo, specializing in Engineering Simulation Software, displayed during CES 2025 in Las Vegas, Nevada, USA, on January 9, 2025. ANSYS software revolutionizes vehicle development by enabling cost-effective virtual design and validation, enhancing safety with simulated risk scenarios, and accelerating innovation with AI-powered simulations to meet evolving industry demands.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.